Filing Details
- Accession Number:
- 0001110803-14-000318
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-09-16 18:28:26
- Reporting Period:
- 2014-09-15
- Filing Date:
- 2014-09-16
- Accepted Time:
- 2014-09-16 18:28:26
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1110803 | Illumina Inc | ILMN | Laboratory Analytical Instruments (3826) | 330804655 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1534166 | Nicholas Naclerio | 5200 Illumina Way San Diego CA 92122 | Sr Vp, Corp Development | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2014-09-15 | 2,000 | $43.37 | 25,146 | No | 4 | M | Direct | |
Common Stock | Disposition | 2014-09-15 | 900 | $168.63 | 24,246 | No | 4 | S | Direct | |
Common Stock | Disposition | 2014-09-15 | 700 | $169.65 | 23,546 | No | 4 | S | Direct | |
Common Stock | Disposition | 2014-09-15 | 200 | $170.65 | 23,346 | No | 4 | S | Direct | |
Common Stock | Disposition | 2014-09-15 | 200 | $171.99 | 23,146 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2014-09-15 | 2,000 | $0.00 | 2,000 | $43.37 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
6,000 | 2011-08-08 | 2020-06-29 | No | 4 | M | Direct |
Footnotes
- The sale was made pursuant to a 10b5-1 plan.
- Weighted average sale price representing 900 shares sold ranging from $168.1234 to $168.99 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
- Weighted average sale price representing 700 shares sold ranging from $169.3343 to $169.84 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
- Weighted average sale price representing 200 shares sold ranging from $170.47 to $170.8292 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.